Bajaj HealthCare Limited (BOM:539872)
363.85
-2.15 (-0.59%)
At close: Jan 21, 2026
Bajaj HealthCare Revenue
Bajaj HealthCare had revenue of 1.63B INR in the quarter ending December 31, 2025, with 32.64% growth. This brings the company's revenue in the last twelve months to 6.11B, up 17.00% year-over-year. In the fiscal year ending March 31, 2025, Bajaj HealthCare had annual revenue of 5.43B with 14.61% growth.
Revenue (ttm)
6.11B
Revenue Growth
+17.00%
P/S Ratio
1.86
Revenue / Employee
6.65M
Employees
918
Market Cap
11.37B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 5.43B | 691.85M | 14.61% |
| Mar 31, 2024 | 4.73B | -1.72B | -26.69% |
| Mar 31, 2023 | 6.46B | -340.94M | -5.01% |
| Mar 31, 2022 | 6.80B | 229.06M | 3.49% |
| Mar 31, 2021 | 6.57B | 2.46B | 59.96% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| IOL Chemicals and Pharmaceuticals | 21.70B |
| Shilpa Medicare | 13.43B |
| Sudeep Pharma | 5.61B |
| Aarey Drugs & Pharmaceuticals | 4.28B |
| NGL Fine-Chem | 4.08B |
| Infinium Pharmachem | 1.57B |
| Gujarat Themis Biosyn | 1.55B |
| Anlon Healthcare | 1.44B |
Bajaj HealthCare News
- 3 months ago - Bajaj Healthcare shares jump nearly 3% after CDSCO approval for Phase III trials of insomnia drug Suvorexant - Business Upturn
- 6 months ago - Why is Bajaj Healthcare stock falling despite 66% jump in Q1 profit? Explained - Business Upturn
- 1 year ago - Bajaj Healthcare shares rise 5% in weak market as Q3 revenue jumps 13% YoY - Business Upturn
- 1 year ago - Corporate Earnings to Watch on February 11: Lupin, Vodafone Idea, Berger Paints, IRCTC, SAIL, and More - Business Upturn
- 1 year ago - Bajaj Healthcare secures DCGI approval to manufacture Pimavanserin in India - Business Upturn
- 1 year ago - Bajaj Healthcare shares surge 12% after securing exclusive rights for Magtein® in India - Business Upturn
- 1 year ago - Bajaj Healthcare secures exclusive rights for Magtein® in India from Threotech LLC - Business Upturn
- 1 year ago - Bajaj Healthcare shares surge 2% on new CDMO agreement with UK/EU clients - Business Upturn